# OnCo record nct05027776 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05027776/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05027776", "NCT05027776" ;
  schema:name "Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years"@en ;
  schema:description "A phase 3 trial of 2-doses Group among 9-14 years in cervical cancer and vaginal cancer, run by Shanghai Bovax Biotechnology Co., Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05027776/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05027776> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2021-09-15" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/vaginal/> ;
  onco:companies <https://onco.cc/companies/shanghai-bovax-biotechnology/> .